• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

27.01 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Forte Biosciences, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
March 17, 2026
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
March 04, 2026
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 09, 2026
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
December 22, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
November 24, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
November 14, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
November 03, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
October 03, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
September 15, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Results and Provides Update
August 14, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences Announces Pricing of $75 Million Public Offering
June 25, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences Announces Proposed Public Offering
June 24, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
June 23, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Results and Provides Update
May 15, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 03, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences to Host R&D Day December 3, 2024
November 25, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
November 20, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
November 14, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
August 14, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
May 17, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
May 13, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
March 18, 2024
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
December 01, 2023
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
November 13, 2023
From Forte Biosciences, Inc.
Via Business Wire
News headline image
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting
September 14, 2023
From On behalf of Concerned Stockholders of Forte
Via Business Wire
News headline image
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom
September 06, 2023
From On behalf of Concerned Stockholders of Forte
Via Business Wire
News headline image
Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders
August 25, 2023
From On behalf of Concerned Stockholders of Forte
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
August 14, 2023
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
August 01, 2023
From Forte Biosciences, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap